AbbVie and AstraZeneca both bring blockbuster drugs, deep pipelines and risks, but their growth paths, pressures and priorities now sharply diverge.
Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.
As a parent, one of your greatest fears is having your child be diagnosed with a life-long illness that has no cure. This became a reality for my family when my daughter, Natalie, went from being a ...
Bank of America's dividend yields 2.1%, but because the company's payout ratio is just 25% of net income, this is one of the most stable dividends you can find. You can buy 30 shares of Bank of ...
Dividend stocks can provide a meaningful path to enhancing your portfolio returns. Investing in businesses with a track record of profitability and favorable cash flows that have the financial ...
AbbVie to present data from multiple studies of Rinvoq, Humira & Skyrizi at the 2019 ACR/ARP) meeting: North Chicago, Illionis Tuesday, November 5, 2019, 16:00 Hrs [IST] AbbVie, a ...
Explore this year's advancements in gastroenterology biosimilars, highlighting key FDA approvals and market dynamics ...
Explore the latest developments in the US biosimilar market, highlighting key approvals, challenges, and future trends shaping patient access in 2025.
Growth and income investors can buy these five top dividend stocks now, tomorrow, next week, or next year and hold for the ...
Erica Meier is quality team and development editor for Health. In her role, she is a champion for those who are seeking health-related information by making jargon-laden medical knowledge available ...
Kambah mum Sarah Fletcher sobbed in the gallery at Senate estimates this week as health bureaucrats were peppered with questions about why potentially life-changing medicine was not being made readily ...
News archive including articles on Fund Managers, Fund Selection, Asset Allocation, Absolute Return, Offshore Investments, Tax Shelters, Insurance bonds. Baillie Gifford’s three stocks driving positiv ...